Abeona Therapeutics, Inc. (ABEO)
5.465
-0.06
(-1.00%)
USD |
NASDAQ |
May 22, 15:22
Abeona Therapeutics Profit Margin (Quarterly) : -195.8% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -524.6K% |
| Plus Therapeutics, Inc. | -675.7% |
| Perspective Therapeutics, Inc. | -34.46K% |
| Myriad Genetics, Inc. | -17.02% |
| Atossa Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 48.60% |
| Return on Assets | 33.19% |
| Return on Invested Capital | 41.30% |
| Gross Profit Margin (Quarterly) | 59.12% |
| Operating Margin (Quarterly) | -264.1% |
| Return on Net Operating Assets | 333.2% |